
Designed for the prostate
Premium comprehensive formula for a healthy prostate,normal urine flow and support potency.


Prostate problems are the most common difficulties that affect men after the age of 40. The first symptoms include a weaker urine stream and more frequent urination. Other typical symptoms that men observe are urgency and intermittent urination, incomplete bladder emptying or frequent nighttime urination. Prostate problems tend to be associated with a higher risk of developing potency problems.

Prostenal Control contains a cutting-edge complex formula to support prostate health, proper urinary function and normal urine flow. In addition, it promotes potency and vitality. Long-term use of Prostenal Control has a significant positive effect on the observed symptoms of prostate problems. * The combination of substances contained in Prostenal Control shows greater effectiveness in prostate-related problems than taking pure saw palmetto 320 mg. *
*Results of the Stada Reservation Study, January 2022





Take 1 tablet daily, preferably after meals. Wash down with plenty of liquid. For optimal effect, it is advisable to take the product for a long time.
saw palmetto extract, anti-caking agents (cellulose, calcium carbonates, silica, talc, magnesium salts of fatty acids), stinging nettle extract, anchorwort extract, stabilisers (cross-linked sodium salt of carboxymethylcellulose, hydroxypropylmethylcellulose), zinc citrate, rice starch, defoamer (polyethylene glycol), emulsifier (sucrose esters with fatty acids), cholecalciferol, pyridoxine hydrochloride, dye (indigotin).

Do not exceed the recommended daily dose. Gluten and lactose free.
Store in a dry and dark place at a temperature below 25 °C.
Manufacturer's address:
STADA PHARMA CZ s. r. o., Siemensova 2717/4, Prague 5 - Stodůlky, Postal Code 155 00
STADA PHARMA CZ s.r.o., Siemensova 2717/4, 155 00 Praha 13 - Stodůlky, CZ, +420 257 888 111, www.stada-pharma.cz
Specifications can be changed without notice. Images are for illustrative purposes only.